Infectious Disease
Merck to start trials investigating single dosing regimen of HPV vaccine
Merck & Co (MSD) plans to start two prospective clinical trials evaluating the safety and efficacy of a single-dose regimen…
Anticipation rises for RSV rollout as positive data emerges
After record-high levels of respiratory syncytial virus (RSV) were seen in several countries, the pharmaceutical landscape for RSV infections has…
Bavarian Nordic’s chikungunya vaccine secures EMA fast-track
Hot on the heels of dropping its cancer vaccine programme, Bavarian Nordic has secured a win in more familiar territory,…
AstraZeneca completes Icosavax acquisition for $1.1bn
AstraZeneca has concluded the acquisition of the US-based clinical-stage biopharmaceutical company Icosavax in a $1.1bn deal. The latest development comes…
FDA grants fast track status to GSK’s bepirovirsen for hepatitis B
The US Food and Drug Administration (FDA) has granted fast track designation to GSK’s bepirovirsen, an investigational treatment for chronic…
Emergent wins $235.8m US defence contract for Anthrax vaccine
The US Department of Defense (DoD) has awarded a procurement contract worth up to $235.8m to Emergent BioSolutions for an…
Curevo looks to challenge GSK’s Shingrix with positive Phase II data
Curevo Vaccine’s varicella-zoster virus vaccine amezosvatein has achieved all primary endpoints, including demonstrating non-inferiority to GSK’s Shingrix in a Phase…
FDA accepts Merck’s pneumococcal vaccine BLA for priority review
The US Food and Drug Administration (FDA) has accepted the new biologics licence application (BLA) for MSD’s investigational 21-valent pneumococcal…
Health Canada authorises Novavax’s updated Covid-19 vaccine
Health Canada has granted expanded authorisation for Novavax’s updated Covid-19 vaccine, Nuvaxovid XBB.1.5 (recombinant protein, adjuvanted) [NVX-CoV2601]. The vaccine is…
Biocon integrates Viatris biosimilars in 31 European countries
Biocon subsidiary Biocon Biologics has successfully integrated Viatris' biosimilars business in 31 countries in Europe. In November 2022, Biocon Biologics…